Hi-Tech Pharmaceuticals, a product development and commercialization partner in Nutraceuticals and OTC Drug Manufacturing, acquired Pennsylvania-based powder processing facility from Nittany Pharmaceuticals. The facility has been a developer and manufacturer of specialty granulated bulk ingredients since 1979.

With the acquisition, Hi-Tech has been able to provide application-specific product development, pilot and commercial manufacturing solutions using fluid bed technology and roller compacting for granulation, agglomeration, microencapsulation, drying & blending of liquid and powder ingredients.

Steve Smith, senior vice-president of Hi-Tech, said, “Powder and particle engineering are important parts of creating the highest quality, most effective products and have long been a part of our manufacturing offerings. Most companies in our industry outsource this highly specialized capability,” said Smith. “Bringing this capability in-house gave us the ability to broaden our product offerings, and helps our customers get to market faster. This was an important step for us, and we feel like it sets us apart from other companies in our industry.”

Stacey Alexander, chief scientific officer for Hi-Tech Pharmaceuticals, said, “The talent and equipment of our four facilities has a rich history of innovation, technology and manufacturing and we’re excited about the opportunity to be creative and do more for our customers,” said Alexander. “Across the supplement, OTC drug & beverage industries, innovation in product forms and delivery systems are a hot trend and a huge driver of value. Our expanded manufacturing capability will help us do that,” he said. “It will also let us work on projects that might have otherwise been impossible or cost prohibitive, which means we can take our customers places we couldn’t before.”